Medicare Analysis of EUA Outpatient Ambulatory Therapies
The medical research community has had blinders on from the very beginning of the pandemic.
Review papers and outcomes analysis have ignored the Association of American Physicians and Surgeons Home Treatment Guide published in October, 2020, featuring the McCullough Protocol.
Additional protocols from FLCCC, Zelenko, and Raoult used similar principles but did not have the backing of a chartered, established medical society.
Yet, the medical orthodoxy has refused to this day to acknowledge any of these protocols existed, were utilized, or resulted in patients not requiring Emergency Use Authorized (EUA) drugs and avoiding hospitalization and death.
Wilcock et al, analyzed Medicare fee-for-service claims data and found that from 2021 forward, 23 percent of patients received acute COVID-19 ambulatory therapy. They concluded that 16 percenty of severe cases could have been avoided.
I have testified in the US Senate that two thirds of all American hospitalizations and deaths could have been avoided with full implementation of the McCullough Protocol as soon as it was initially published in The American Journal of Medicine, August 6, 2020, and certainly by October, 2020 with the widely disseminated AAPS Home Treatment Guide.
The Wilcock paper is important because the authors point to a preventable fraction. We can only conclude that the proportion of hospitalization and deaths must have been enormous, potentially 85 percent if we would have had a global “home treatment first” for high-risk patients with their first case of COVID-19.
We we should never wait for the government to provide EUA drugs in a pandemic.
As Wilcock and colleagues found, these drugs come too late, are poorly utilized, and may not be optimally used in combination with other drugs, so the population benefit is modest.
Only early empiric multidrug therapy has the potential for a large, life-saving nationwide impact because its used immediately, leverages signals of benefit and acceptable safety, and is commercially available at the outset of the next pandemic.
See more here substack.com
Header image: Getty Images
Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.